Workflow
Xin Lang Cai Jing
icon
Search documents
股价跌超40%!“中国版英伟达”VS“中国版AMD”公布首份财报!你更看好哪个?
Xin Lang Cai Jing· 2026-03-04 11:53
Core Viewpoint - Both Muxi Co., Ltd. (沐曦股份) and Moer Thread (摩尔线程) have reported significant revenue growth and reduced losses for the year 2025, highlighting their positions as leading players in the domestic GPU market and attracting investor interest [1][9]. Group 1: Financial Performance - Muxi Co., Ltd. achieved a total revenue of 1.644 billion yuan in 2025, representing a year-on-year increase of 121.26%, while Moer Thread reported revenue of 1.506 billion yuan, with a remarkable growth rate of 243.37%, double that of Muxi [3][13]. - In terms of loss reduction, Muxi Co., Ltd. reported a net loss of 781 million yuan, narrowing by 44.53%, whereas Moer Thread's net loss was 1.024 billion yuan, with a reduction of 36.70% [4][14]. - Muxi Co., Ltd. saw total assets grow by 251.56% and equity attributable to shareholders increase by 1018%, while Moer Thread's total assets and equity grew by 116.14% and 154.69%, respectively [4][14]. Group 2: Strategic Focus and Market Position - Muxi Co., Ltd. follows a "1+6+X" development strategy, focusing on high-performance GPU market expansion, which has led to a significant increase in GPU product shipments and revenue growth [5][15]. - Moer Thread emphasizes the development of all-functional GPUs, successfully launching the MTTS5000 model, which has achieved market-leading performance and large-scale production [6][15]. - Both companies acknowledge their ongoing high R&D investment phase, with Moer Thread specifically noting the need to enhance its R&D capabilities compared to international giants [6][16]. Group 3: Industry Outlook and Challenges - The performance growth of both companies reflects the potential of the domestic GPU market, driven by the dual benefits of AI computing demand and domestic substitution [7][17]. - Despite their growth, both companies face common challenges, including the high R&D costs inherent in the technology-intensive GPU industry and the need to bridge the gap in core technology and product ecosystem compared to international competitors [7][17]. - Muxi Co., Ltd. benefits from leading revenue scale and greater loss reduction, while Moer Thread stands out with its high revenue growth rate and advanced product capabilities [8][18].
关于同意中信证券股份有限公司为摩根恒生生物科技交易型开放式指数证券投资基金提供主做市服务的公告
Xin Lang Cai Jing· 2026-03-04 10:42
特此公告。 上证公告(基金)【2026】436号 为促进摩根恒生生物科技交易型开放式指数证券投资基金(以下简称港股生物,基金代 码:520760)的市场流动性和平稳运行,根据《上海证券交易所基金自律监管规则适用指引第2号——上 市基金做市业务》等相关规定,本所同意中信证券股份有限公司自2026年03月05日起为港股生物提供主 做市服务。 上海证券交易所 2026年03月04日 ...
渤海银行:聘任屈宏志兼任首席合规官
Xin Lang Cai Jing· 2026-03-04 10:09
Group 1 - The board of Bohai Bank has approved the appointment of Mr. Qu Hongzhi as the Chief Compliance Officer, effective from March 4, 2026, until the end of the term of the current president [1][2]
瑞幸咖啡支持者大钲资本据称正就收购蓝瓶咖啡进行深入洽谈
Xin Lang Cai Jing· 2026-03-04 09:58
Core Viewpoint - Dazhong Capital is in advanced negotiations to acquire Blue Bottle Coffee, a subsidiary of Nestlé, although the deal is not guaranteed to close [1][2][3] Group 1: Acquisition Details - Dazhong Capital is finalizing the acquisition of Blue Bottle Coffee, a coffee roasting and retail company [2][3] - The negotiations are at a stage where an agreement could be reached soon, but there is no certainty of completion [2][3] - Dazhong Capital has previously assisted Luckin Coffee in turning around its business [2][3] Group 2: Company Background - Blue Bottle Coffee was founded in 2002 in Oakland, California, and has locations in the United States, China, Japan, Singapore, and South Korea [2][3] - Nestlé invested approximately $425 million in 2017 to acquire a 68% stake in Blue Bottle Coffee [2][3] Group 3: Market Context - Dazhong Capital and Luckin Coffee have been evaluating multiple coffee chain targets, including Blue Bottle, Costa Coffee, and the operator of % Arabica stores in China [2][3]
投资者提问:请问公司通过 莫仕 泰科 安费诺向英伟达和谷歌供应哪些零部件?
Xin Lang Cai Jing· 2026-03-04 09:56
Core Viewpoint - The company provides precision die-casting services, supplying components such as optical communication modules and connectors to clients including Tyco, Molex, Amphenol, Nvidia, and Google [1] Group 1 - The company engages in precision die-casting business [1] - Key clients include Tyco, Molex, and Amphenol [1] - Products supplied include optical communication modules and connectors [1]
小马智行在浙江设立新公司 注册资本5000万美元
Xin Lang Cai Jing· 2026-03-04 09:38
Group 1 - The core viewpoint of the article is that the autonomous driving company Pony.ai has established a new subsidiary in Zhejiang, China, named Zhejiang Pony Easy Mobility Technology Co., Ltd. with a registered capital of 50 million USD [1] - The new company's business scope includes software outsourcing, information technology consulting, computer system services, sales of communication and artificial intelligence hardware, and sales of complete electric vehicles [1] - The new subsidiary is wholly owned by Hong Kong Pony.ai, indicating a strategic expansion in the Chinese market [1]
民生银行今日大宗交易平价成交1196.1万股,成交额4593万元
Xin Lang Cai Jing· 2026-03-04 09:36
Group 1 - The trading date for the transactions is March 4, 2026, indicating recent activity in the market [1] - The security involved is Minsheng Bank, with the stock code 600016, and the trading price was 3.84 yuan [1] - The total transaction amount for Minsheng Bank was 4,592.99 million yuan, with a total trading volume of 1,196.10 thousand shares [1] Group 2 - The buying brokerage firms include Guotai Junan Securities and Huatai Securities [1] - The selling brokerage firm is also Huatai Securities, indicating potential internal trading dynamics [1]
特斯拉“铁粉”斥资上亿美金加仓英伟达 称AI浪潮非泡沫
Xin Lang Cai Jing· 2026-03-04 08:57
格隆汇3月4日丨亿万富翁Leo KoGuan曾在几年前以特斯拉(TSLA.US)最大个人股东之一的身份崭露头 角,他表示周二买入了100万股英伟达(NVDA.O)股票。Leo 周三在X平台上发布贴文称:"我坚信AI不 是泡沫,这仅仅是开始。"随后他补充道:"计划很快再买入100万股英伟达。以此向紧张的市场表示支 持。"英伟达周二在纽约收盘报180.05美元,这意味着这位71岁的亿万富翁大约支付了1.8亿美元。根据 亿万富翁指数,他的身家达128亿美元。 来源:格隆汇APP ...
新华制药:获得恩他卡朋片药品注册证书
Xin Lang Cai Jing· 2026-03-04 08:49
Core Viewpoint - The company has received approval from the National Medical Products Administration for the registration of Entacapone tablets, which are prescription drugs that assist in the treatment of Parkinson's disease and end-of-dose wearing-off phenomena, classified as a Category B item in the medical insurance directory [1] Group 1 - The approved drug is expected to generate approximately 286 million yuan in sales for public medical institutions in China in 2024 [1] - This approval enhances the company's formulation product portfolio and improves its overall competitiveness [1] - The sales of the drug may be influenced by policies and market factors, leading to uncertainties [1]
长江证券:维持比亚迪“买入”评级,盈利能力有望继续提升
Xin Lang Cai Jing· 2026-03-04 08:49
Core Viewpoint - BYD's overall sales in February reached 190,000 units, showing a year-on-year decline of 41.1% and a month-on-month decrease of 9.5% [1] Sales Performance - Passenger vehicle sales totaled 188,000 units, reflecting a year-on-year drop of 41.0% and a month-on-month decline of 8.6% [1] - Export sales exceeded 100,000 units, indicating strong international demand [1] Market Outlook - The company is poised for growth with new technologies and product cycles expected to drive performance in March, entering the peak season [1] - As the global leader in new energy vehicles, BYD is building competitive advantages through technology and scale [1] Strategic Initiatives - The company is committed to its smart driving transformation under its intelligent strategy [1] - A rich lineup of models including Tengshi, Yangwang, and Fangchengbao is accelerating its entry into the high-end market [1] Profitability Expectations - Continued efforts in international expansion and high-end market penetration are anticipated to enhance profitability [1] - The company forecasts a net profit of 35 billion yuan by 2025, corresponding to a PE ratio of 23X, maintaining a "buy" rating [1]